Barner H B
Heart Institute, Long Island Jewish Medical Center, New Hyde Park, NY 11042.
Ann Thorac Surg. 1991 Dec;52(6):1354-67. doi: 10.1016/0003-4975(91)90034-n.
The Oxford International Symposium on myocardial preservation provided an appropriate milestone and impetus to survey one aspect of operative myocardial preservation, namely blood cardioplegia, and to contrast it with the more popular crystalloid cardioplegia. This review is by no means complete or exhaustive but represents my best effort to summarize important information that has accumulated in the literature as blood cardioplegia, and our understanding of it, has evolved. It is appropriate to compare blood and crystalloid cardioplegia with respect to biochemical and physiological differences. Clinical comparison has been limited, for the most part, to randomized studies, and a number of differences and details of clinical management of the two techniques have been omitted, either because they seemed unimportant or there was no good information that would allow an objective comparison of their significance. Hopefully, the reader will recognize the intent to focus on meaningful differences and similarities between the two techniques and to present them fairly.
牛津国际心肌保护研讨会为审视手术心肌保护的一个方面——即血液停搏液，提供了一个合适的里程碑和推动力，并将其与更常用的晶体停搏液进行对比。这篇综述绝非完整或详尽无遗，但代表了我最大的努力，以总结随着血液停搏液在文献中积累的重要信息以及我们对它的理解的演变。就生化和生理差异方面比较血液停搏液和晶体停搏液是恰当的。临床比较在很大程度上局限于随机研究，并且这两种技术在临床管理上的一些差异和细节被省略了，要么是因为它们似乎不重要，要么是没有能客观比较其重要性的良好信息。希望读者能认识到本文旨在聚焦于这两种技术之间有意义的差异和相似之处，并公正地呈现它们。
